|Application ||WB, IHC-P, IHC-F, IF, FC, E, IP, EM|
|Calculated MW||14177 Da|
|Purification||Purified IgG prepared by affinity chromatography on Protein A from tissue culture supernatant|
|Immunogen||Thymocytes and T lymphocytes.|
|Shelf Life||18 months from date of despatch.|
|Other Names||CD59 glycoprotein, 1F5 antigen, 20 kDa homologous restriction factor, HRF-20, HRF20, MAC-inhibitory protein, MAC-IP, MEM43 antigen, Membrane attack complex inhibition factor, MACIF, Membrane inhibitor of reactive lysis, MIRL, Protectin, CD59, CD59, MIC11, MIN1, MIN2, MIN3, MSK21|
|Target/Specificity||Mouse anti-Human CD59 antibody, clone MEM-43 recognizes CD59, a glycosyl-phosphatidylinositol (GPI) anchored membrane protein also known as membrane attack complex inhibition factor. CD59 blocks the formation of the complement membrane attack complex (MAC) by binding of C8a and C9. CD59 is found on all types of leucocytes including platelets and is also expressed on many non-haematopoietic cells. The epitope recognized by Mouse anti-Human CD59 antibody, clone MEM-43 is lost after reduction therefore, non-reducing conditions are required for western blotting techniques.|
|Preservative & Stabilisers||0.09% Sodium Azide|
|Storage||Store at +4℃ or at -20 ℃.|
|Precautions||Anti-Human CD59 Antibody, clone MEM-43 is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
1. Stefanova, I. et al. (1989) in Leucocyte Typing IV: White cell differentiation antigens.Ed. Knapp, W. et al. Oxford University Press pp 678-697. 2. Stefanova, I. et al. (1989) Characterisation of a broadly expressed human leucocyte surface antigen MEM-43 anchored in membrane through phosphotidylinositol. Mol. Immunol. 26: 153 - 161. 3. Tandon, N. et al. (1994) . Expression and function of multiple regulators of complement activation in autoimmune thyroid disease.Immunology 81: 643-647. 4. Horejsi, V. et al. (1988) Monoclonal antibodies against human leucocyte antigens. II. Antibodies against CD45 (T200), CD3 (T3), CD43, CD10 (CALLA), transferrin receptor (T9), a novel broadly expressed 18-kDa antigen (MEM-43) and a novel antigen of restricted expression (MEM-74). Folia. Biol. (Prague) 34: 23-24. 5. Stefanova, I. et al. (1991) Association of the CD59 and CD55 cell surface glycoproteins with other membrane molecules. J. Immunol. 147: 1587 - 1592. 6. Shaw, M.L. et al. (2008) Cellular proteins in influenza virus particles.PLoS Pathog. 4: e1000085. 7. Sadallah, S. et al. (2011) Microparticles (ectosomes) shed by stored human platelets downregulate macrophages and modify the development of dendritic cells.J Immunol. 186: 6543-52. 8. Jolly, C, and Sattentau. Q.J. (2005) Human Immunodeficiency Virus Type 1 Virological Synapse Formation in T Cells Requires Lipid Raft IntegrityJ Virol. 79: 12088-94. 9. Shamri, R. et al. (2002) Chemokine stimulation of lymphocyte alpha 4 integrin avidity but not of leukocyte function-associated antigen-1 avidity to endothelial ligands under shear flow requires cholesterol membrane rafts.J Biol Chem. 277: 40027-35. 10. Bonnon, C. et al. (2010) Selective export of human GPI-anchored proteins from the endoplasmic reticulum.J Cell Sci. 123: 1705-15. 11. Zhang, J. et al. (2002) Early complement activation and decreased levels of glycosylphosphatidylinositol-anchored complement inhibitors in human and experimental diabetic retinopathy.Diabetes. 51: 3499-504. 12. Ellison, B.S. et al. (2007) Complement susceptibility in glutamine deprived breast cancer cells.Cell Div. 2007 2: 20. 13. Cowan, P.J. et al. (1998) High-level endothelial expression of human CD59 prolongs heart function in an ex vivo model of xenograft rejection.Transplantation. 65: 826-31. 14. Vanderplasschen, A. et al. (1997) Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope.Proc Natl Acad Sci U S A. 95: 7544-9. 15. Takemoto, M. et al. (2007) Human herpesvirus 7 infection increases the expression levels of CD46 and CD59 in target cells.J Gen Virol. 88: 1415-22. 16. Chong, Y.H. and Lee, M.J. (2000) Expression of complement inhibitor protein CD59 in human neuronal and glial cell lines treated with HIV-1 gp41 peptides.J Neurovirol. 6: 51-60. 17. Gendek-Kubiak, H. and Gendek, E.G. (2004) Immunolocalization of protectin (CD59) and macrophages in polymyositis and dermatomyositis.J Neuroimmunol. 149: 187-94.
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.
Request Quote Here